首页> 外文期刊>International Journal of Nanomedicine >Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability
【24h】

Pharmacology and Pharmacokinetics of Vitamin E: Nanoformulations to Enhance Bioavailability

机译:维生素E的药理学和药代动力学,纳米型植物增强生物利用度

获取原文
       

摘要

Vitamin E belongs to the family of lipid-soluble vitamins and can be divided into two groups, tocopherols and tocotrienols, with four isomers (alpha, beta, gamma and delta). Although vitamin E is widely known as a potent antioxidant, studies have also revealed that vitamin E possesses anti-inflammatory properties. These crucial properties of vitamin E are beneficial in various aspects of health, especially in neuroprotection and cardiovascular, skin and bone health. However, the poor bioavailability of vitamin E, especially tocotrienols, remains a great limitation for clinical applications. Recently, nanoformulations that include nanovesicles, solid-lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, and polymeric nanoparticles have shown promising outcomes in improving the efficacy and bioavailability of vitamin E. This review focuses on the pharmacological properties and pharmacokinetics of vitamin E and current advances in vitamin E nanoformulations for future clinical applications. The limitations and future recommendations are also discussed in this review.? 2020 Mohd Zaffarin et al.
机译:维生素E属于脂质可溶性维生素系列,可分为两组,生育酚和Tocotrienols,其中四个异构体(α,β,γ和δ)。虽然维生素E被广泛称为有效的抗氧化剂,但研究也揭示了维生素E具有抗炎性质。维生素E的这些关键性质在健康的各个方面有益,特别是在神经保护和心血管,皮肤和骨骼健康中。然而,维生素E,尤其是Tocotrienols的不良生物利用度仍然是对临床应用的巨大限制。最近,包括纳米粒子,固体脂质纳米颗粒,纳米结构脂质载体,纳米乳液和聚合物纳米颗粒的纳米型族种已经显示出提高维生素E的功效和生物利用度的有希望的结果。本综述侧重于维生素E和当前进步的药理学性质和药代动力学在维生素E纳米型纳米型临床应用中。本次审查还讨论了局限性和未来的建议。 2020 Mohd Zaffarin等人。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号